ArticleEpidemiology and infection2014
Characterization of a novel international clonal complex (CC32) of Acinetobacter baumannii with epidemic potential.
Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Carbapenem-ResistantMicroorganisms · 2025Review
- Epidemiological and genomic analysis ofHeliyon · 2025Article
- Clonal diversity ofNew microbes and new infections · 2021Article
- NDM-1 carbapenemase inNew microbes and new infections · 2019Article
- Comparative Analysis of the TwoFrontiers in microbiology · 2019Article
- Seasonal Occurrence and Carbapenem Susceptibility of BovineFrontiers in microbiology · 2019Article
- Insights on the Horizontal Gene Transfer of Carbapenemase Determinants in the Opportunistic Pathogen Acinetobacter baumannii.Microorganisms · 2016Review
- Dissemination of carbapenemases producing Gram negative bacteria in the Middle East.Iranian journal of microbiology · 2015Review
- Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait.Frontiers in microbiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Twelve non-replicate Acinetobacter baumannii isolates from five European hospitals, Kuwait, and the US military healthcare system collected between 1980 and 2005 revealed a new clone, CC32. These included representative isolates of outbreaks/cross-infections. Antimicrobial susceptibility and carbapenem-resistant genetic traits varied. The widespread occurrence, the association with an outbreak and the carbapenem resistance indicate that CC32 has epidemic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.